000 01316 a2200337 4500
005 20250516002524.0
264 0 _c20101104
008 201011s 0 0 eng d
022 _a1550-6606
024 7 _a10.4049/jimmunol.1001892
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOh, Jason Z
245 0 0 _aThe capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cOct 2010
300 _a4602-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntigens
_ximmunology
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCross-Priming
_ximmunology
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aMembrane Glycoproteins
_xagonists
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aOvalbumin
_ximmunology
650 0 4 _aToll-Like Receptor 7
_xagonists
650 0 4 _aVaccines, Conjugate
_ximmunology
700 1 _aKedl, Ross M
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 185
_gno. 8
_gp. 4602-8
856 4 0 _uhttps://doi.org/10.4049/jimmunol.1001892
_zAvailable from publisher's website
999 _c20174849
_d20174849